27 June 2017 - A new therapeutic approach to the Becker muscular dypriophy, signed agreement
The signature meeting was held at the Regione Lombardia premises in the afternoon of June 27, 2017.
13 April 2017 - POR FESR 2014-2020: Linea innovazione (Innovation line)
The Italfarmaco's project "ITF-Becker a new therapeutic approach at the Becker Muscular Dystrophy (BMD)"
17 March 2017 - Peripheral occlusive arterial disease (PAD)
European objective of no amputations with early diagnosis and proper prevention; proper therapy could reduce amputations by 70%
02 March 2016 - Market launch of Akynzeo
Market launch of Akynzeo, new NK-1 antagonist serotonergic
30 September 2015 - Acquisition of Effik, S.A.
Italfarmaco Group announces the acquisition of the remaining 50% in Effik, S.A.
29 September 2015 - New Italfarmaco representative office in Vietnam
Opening of the new Group representative Office
31 July 2014 - GMP Approval by Turkish Authorities
Approval of the Italfarmaco manufacturing plant of Milan
30 June 2014 - FDA approves the registration of Enoxaparine
The manufacturing is started at the Italfarmaco manufacturing plant of Milan
11 June 2014 - Inauguration of the new branch office in Moscow
Inauguration of the new Italfarmaco representative office in Moscow
29 November 2013 - New manufacturing plant
Inauguration of the new chemical-pharmaceutical manufacturing plant of ITF Chemical (Bahia-Brasil)